Telangana, India

Keerthi Priya

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Keerthi Priya: Innovator in Pharmaceutical Compositions

Introduction

Keerthi Priya is a prominent inventor based in Telangana, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug bioavailability. With a total of five patents to her name, her work is paving the way for advancements in medication administration.

Latest Patents

Her latest patents focus on pharmaceutical compositions of nilotinib, specifically amorphous solid dispersions of nilotinib fumarate or nilotinib tartrate. These compositions are designed to exhibit enhanced bioavailability in the fasted state. They can be orally administered to patients in either the fed or fasted state, effectively decreasing or eliminating the food effect. Following oral administration, there is no substantial difference in the pharmacokinetic parameters of nilotinib, regardless of the patient's state during administration.

Career Highlights

Keerthi has worked with notable companies in the pharmaceutical industry, including Slayback Pharma LLC and Azurity Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in drug formulation.

Collaborations

Some of her notable coworkers include Paras P Jain and Ajay Kumar Singh. Their collaboration has further enriched her work and has led to advancements in the pharmaceutical field.

Conclusion

Keerthi Priya's innovative work in pharmaceutical compositions demonstrates her commitment to improving drug delivery systems. Her contributions are vital in enhancing patient care and medication efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…